Premade Adenovirus Vectors from ViraQuest
ViraQuest Inc. is a biotechnology company specializing in the production of adenoviral vectors and retains the exclusive commercial rights to RAPAd® technology. Using the patented processes unique to RAPAd® (U.S. Patent #6,830,920) for the generation of new constructs, they have produced many premade adenviruses now made available to KeraFAST customers.
Custom Adenovirus Production Available
ViraQuest offers an array of adenovirus services to meet your needs including new constructs, dual-expressing vectors, amplifications and isolations. They can provide the fastest turn around time of any supplier in the industry. Utilizing the RAPAd® technology combined with easy subcloning steps results in production of your custom adenovirus constructs in as little as three weeks without complications of revertants. Request a quote »
- Anderson RD, Haskell RE, Xia H, Roessler BJ, and Davidson BL. A Simple Method for the Rapid Generation of Recombinant Adenovirus Vectors. Gene Therapy. (2000) 7, 1034-1038.
- Lee MY, Garvey SM, Ripley ML, Wamhoff BR. Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2665-75.
- Vojnov L, Bean AT, Peterson EJ, Chiuchiolo MJ, Sacha JB, Denes FS, Sandor M, Fuller DH, Fuller JT, Parks CL, McDermott AB, Wilson NA, Watkins DI. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4? T cells, but few subdominant epitope-specific CD8? T cells. Vaccine. 2011 Oct 6;29(43):7483-90.
- Orcutt KP, Parsons AD, Sibenaller ZA, Scarbrough PM, Zhu Y, Sobhakumari A, Wilke WW, Kalen AL, Goswami P, Miller FJ Jr, Spitz DR, Simons AL. Erlotinib-mediated inhibition of EGFR signaling induces metabolic oxidative stress through NOX4. Cancer Res. 2011 Jun 1;71(11):3932-40.
- Yin JX, Yang RF, Li S, Renshaw AO, Li YL, Schultz HD, Zimmerman MC. Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current. Am J Physiol Cell Physiol. 2010 Apr;298(4):C857-65.